Profile every Fc receptor, serum binder, and DEL hit on one device

Drug discovery demands high-throughput binding measurements across diverse compound classes, protein targets, and biological matrices. Yet most label-free biosensors require purified samples and measure one compound at a time. The MACS Matchmaker, based on focal molography, breaks both limits: up to 64 simultaneous interactions per chip, label-free, in undiluted plasma, serum, or cell lysate.

Application 1: 8-plex Fc receptor profiling panel

FcγRI, FcγRIIa, FcγRIIb, FcγRIIIa, FcγRIIIb, FcεRI, FcεRII, and the neonatal Fc receptor (FcRn) co-immobilized via DNA-directed immobilization (DDI) on a single chip. Antibody candidates injected as analytes give a full effector function profile from a single experiment, directly in development buffer. The profile discriminates IgG subclasses (IgG1, IgG2, IgG4) and engineered Fc variants (LALA, GASDALIE, YTE).

Application 2: serum protein binding

Three FDA-approved anti-CD20 antibodies (rituximab, obinutuzumab, ofatumumab) profiled in human serum within a 1-hour single-cycle kinetic run. Apparent dissociation constants (K_D) cluster around 1 µM in full human serum. A partially humanized reference antibody shows a distinctly different serum-interaction profile (~4× higher K_D). The MACS Matchmaker delivers the answer in plasma, in parallel, in one hour, a question SPR cannot answer.

Application 3: on-DNA DEL hit validation

Conventional DNA-encoded library (DEL) hit validation requires off-DNA synthesis, the hit made again without its DNA tag, before biophysical testing. That route has a 70 to 90 percent false-positive rate and takes weeks to months. Focal molography enables direct on-DNA affinity measurement of intact DEL hits via DDI. It ranks k_on, k_off, and K_D per compound with the same library prep used for screening. Lower false positives, hours instead of weeks, and LC-MS identifies which binds.

Presented at PEGS Boston 2026, Booth 615 (Poster A073). Authors: Lukas Heuberger, Alexander Geiger, Andreas Frutiger, Simona Notova, Volker Gatterdam, lino Biotech AG (a Miltenyi Biotec Company).

Download the Full Poster

Fill in the form below to receive the complete PEGS Boston 2026 poster (A073) in your inbox. Full kinetic data, dissociation constants, and platform specifications included.